Dr. Patrick James Mclaren, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1542 Tulane Ave # 734, New Orleans, LA 70112 Phone: 504-468-4750 |
Dr. Ian C. Carmody, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 |
Dr. Michael Thomas Weaver, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3715 Prytania St, Ste 400, New Orleans, LA 70115 Phone: 504-897-8276 Fax: 504-897-8336 |
Ryan Phillips, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-6829 Fax: 504-842-0089 |
William D Aukerman, MD Surgery Medicare: Medicare Enrolled Practice Location: 1430 Tulane Ave, New Orleans, LA 70112 Phone: 801-703-6663 |
Christopher George Trahan, MD Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 1717 St Charles Ave, New Orleans, LA 70130 Phone: 504-899-2800 Fax: 504-899-2700 |
Mitchell Evan Temple, MD Surgery Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-846-9646 |
Dr. Alexandros Nicolaou Flaris, MD Surgery Medicare: Medicare Enrolled Practice Location: 1430 Tulane Ave, Department Of Surgery, New Orleans, LA 70112 Phone: 504-988-5111 |
Dr. Valentine Nfongen Nfonsam, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1542 Tulane Ave Rm 747a, New Orleans, LA 70112 Phone: 504-568-4750 |
News Archive
Gov. Gavin Newsom made a bold move Wednesday. In his second State of the State address, an annual speech that usually focuses on political wins or the state's booming economy, Newsom dedicated 35 of 42 minutes to the urgent but unsexy issue of homelessness.
Johns Hopkins researchers have developed the basis of an inexpensive, simple urine test that identifies impending kidney failure or rejection following transplant surgery. Their work, presented this week in a special invited lecture to the American Transplant Congress in Boston, Mass., is based on proteins found in urine, and could lead to a urine test kit that may allow many patients to skip painful biopsies.
Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.
Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: "HXBPF") today announced that it has accepted subscriptions for the purchase, by way of private placement, of a total of 6,625,000 units at $2.05 per unit, for gross proceeds totaling CDN$13,581,250.
The National Institute for Clinical Excellence (NICE) has today issued guidance to the NHS in England and Wales on the use of newer drugs for the treatment of epilepsy in adults.
› Verified 7 days ago